1. Home
  2. PLNT vs CYTK Comparison

PLNT vs CYTK Comparison

Compare PLNT & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Fitness Inc.

PLNT

Planet Fitness Inc.

HOLD

Current Price

$97.35

Market Cap

9.1B

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$62.50

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLNT
CYTK
Founded
1992
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
8.0B
IPO Year
2015
2004

Fundamental Metrics

Financial Performance
Metric
PLNT
CYTK
Price
$97.35
$62.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
16
Target Price
$118.83
$82.38
AVG Volume (30 Days)
1.7M
2.2M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
31.23
N/A
EPS
2.44
N/A
Revenue
$1,202,700,000.00
$87,211,000.00
Revenue This Year
$21.43
$339.72
Revenue Next Year
$11.05
$79.08
P/E Ratio
$40.03
N/A
Revenue Growth
14.63
2609.26
52 Week Low
$87.72
$29.31
52 Week High
$114.47
$70.98

Technical Indicators

Market Signals
Indicator
PLNT
CYTK
Relative Strength Index (RSI) 30.62 47.75
Support Level $98.26 $60.30
Resistance Level $108.49 $65.08
Average True Range (ATR) 3.51 2.91
MACD -1.24 -0.01
Stochastic Oscillator 12.45 45.74

Price Performance

Historical Comparison
PLNT
CYTK

About PLNT Planet Fitness Inc.

Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: